article thumbnail

Celltrion’s Yuflyma receives US FDA approval for multiple conditions

Pharmaceutical Technology

Yuflyma represents the company’s fifth biosimilar and second anti-TNF biosimilar to receive US FDA approval. The regulatory approval was based on a comprehensive data package of preclinical, analytical and clinical trials. It will be offered to patients in prefilled syringe and autoinjector administration options.

article thumbnail

Top 15 Diabetes Drugs in 2023 by 2022 Sales Statistics

XTalks

The top 15 diabetes drugs in 2023, according to 2022 sales data, reflect the current state of diabetes management and hint at the evolving needs and trends within this critical area of healthcare. Read on to learn more about the top 15 diabetes drugs in 2023, based on 2022 sales statistics. mL subcutaneous solution (2 mg/1.5

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ortho-Phthalates in Food Packaging + McDonald’s New Restaurant Idea – Xtalks Food Podcast Ep. 121

XTalks

Last month, the US Food and Drug Administration (FDA) stood by its decision, denying a petition asking it to reevaluate the use of eight ortho-phthalates in food-contacting packaging materials. A prime example is Grimace, whose limited-edition purple shake triggered a TikTok frenzy.

article thumbnail

Lilly injects $450m into plant making Mounjaro

pharmaphorum

It will boost the site’s its capacity for parenteral filling, device assembly and packaging even further. In its third-quarter results, Lilly said that the early take-up of Mounjaro had been “ viral in nature ,” with sales approaching $100 million even though it only got FDA approval for diabetes the previous May.

Sales 97
article thumbnail

Pink Sauce: Everything You Need to Know About TikTok’s Controversial Condiment

XTalks

Yet over the past few weeks, she’s faced numerous questions about Pink Sauce’s ingredients, packaging and marketing, prompting a social media-based food scandal. Several other customers said they received leaking bottles of rotten-smelling sauce in the mail, with approximately 50 packages being impacted. FDA-Approved?

article thumbnail

Mallinckrodt’s long haul with terlipressin in US ends in approval

pharmaphorum

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. The drug is already approved for this indication in dozens of other countries around the world, including much of Europe, Australia and New Zealand.

article thumbnail

Mallinckrodt tries again with kidney drug terlipressin

pharmaphorum

Manufacturing problems wreaked havoc with Mallinckrodt’s first attempt to secure FDA approval of its treatment candidate terlipressin for hepatorenal syndrome (HRS), but the drugmaker is having another attempt. There is no FDA-approved therapy available.

Drugs 59